Amarin | AMRN - Deudores Comerciales

Precio De Mercado
14.48
Cambio Diario
-0.30 -2.03%
Mensual
-11.27%
Anual
55.70%
Q2 Expectativa
14.06




Deudores Comerciales Cambio Fecha
AbbVie USD 12.77B 132M 2025-09
Alnylam Pharmaceuticals USD 777.57M 187.2M 2025-12
Amarin USD 126.83M 477K 2025-12
AstraZeneca USD 19.05B 1.49B 2025-12
BioCryst Pharmaceuticals USD 106.82M 15.49M 2025-12
DBV Technologies USD 15.97M 279K 2025-09
Esperion Therapeutics USD 140.19M 21.21M 2025-12
GlaxoSmithKline GBP 7.76B 545M 2025-12
Halozyme Therapeutics USD 441.27M 95.24M 2025-12
Heron Therapeutics USD 89.59M 8.54M 2025-12
Ionis Pharmaceuticals USD 66M 41.39M 2025-12
Nektar Therapeutics USD 1.78M 1.12M 2025-12
Neurocrine Biosciences USD 686.8M 41.2M 2025-12
Novartis USD 12.29B 3.3B 2025-12